These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 30170180

  • 1. Antibody-mediated rejection in the Banff classifications of 2007 and 2017: A comparison of renal graft loss prediction capability.
    Solar-Cafaggi D, Marino L, Uribe-Uribe N, Morales-Buenrostro LE.
    Transpl Immunol; 2018 Dec; 51():40-44. PubMed ID: 30170180
    [Abstract] [Full Text] [Related]

  • 2. Microvascular inflammation in early protocol biopsies of renal allografts in cases of chronic active antibody-mediated rejection.
    Tsuji T, Yanai M, Itami H, Ishii Y, Akimoto M, Fukuzawa N, Harada H, Fukasawa Y.
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():26-30. PubMed ID: 26031582
    [Abstract] [Full Text] [Related]

  • 3. Impact of the Banff 2013 classification on the diagnosis of suspicious versus conclusive late antibody-mediated rejection in allografts without acute dysfunction.
    Gimeno J, Redondo D, Pérez-Sáez MJ, Naranjo-Hans D, Pascual J, Crespo M.
    Nephrol Dial Transplant; 2016 Nov; 31(11):1938-1946. PubMed ID: 27312147
    [Abstract] [Full Text] [Related]

  • 4. Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.
    Haas M, Mirocha J, Reinsmoen NL, Vo AA, Choi J, Kahwaji JM, Peng A, Villicana R, Jordan SC.
    Kidney Int; 2017 Mar; 91(3):729-737. PubMed ID: 28104301
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Bortezomib for refractory acute antibody-mediated rejection in kidney transplant recipients: A single-centre case series.
    De Sousa-Amorim E, Revuelta I, Diekmann F, Cofan F, Lozano M, Cid J, Palou E, Sole M, Campistol JM, Oppenheimer F.
    Nephrology (Carlton); 2016 Aug; 21(8):700-4. PubMed ID: 26492594
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After Desensitization.
    Vo AA, Sinha A, Haas M, Choi J, Mirocha J, Kahwaji J, Peng A, Villicana R, Jordan SC.
    Transplantation; 2015 Jul; 99(7):1423-30. PubMed ID: 25606792
    [Abstract] [Full Text] [Related]

  • 10. Defining the Etiology of Renal Allograft Dysfunction Using Banff 2019 Classification: Correlation with Post-Transplant Duration and Creatinine Levels-A Comprehensive Analysis of 200 Renal Biopsies at a Tertiary Care Medical Center Hospital.
    Saleem R, Nasir H, Chakravarty T, Mansoor I, Alazawi S, Ballouk C, Abdulwaasey M, Shaker N, Sangueza OP, Shaker N.
    Int J Surg Pathol; 2024 Oct 03; ():10668969241283737. PubMed ID: 39360394
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Current pathological perspectives on chronic rejection in renal allografts.
    Hara S.
    Clin Exp Nephrol; 2017 Dec 03; 21(6):943-951. PubMed ID: 27848058
    [Abstract] [Full Text] [Related]

  • 15. Role of time from transplantation to biopsy in histologic ABMR: A single center report.
    Chancay J, Liu C, Chauhan K, Andersen L, Harris C, Coca S, Delaney V, Tedla F, De Boccardo G, Sehgal V, Moledina D, Formica R, Reghuvaran A, Banu K, Florman S, Akalin E, Shapiro R, Salem F, Menon MC.
    Clin Transplant; 2022 Dec 03; 36(12):e14802. PubMed ID: 36069577
    [Abstract] [Full Text] [Related]

  • 16. Clinical Significance of Revised Banff Criteria in the Diagnosis of Antibody-Mediated Rejection.
    Jeong HS, Kim DG, Lee ST, Huh KH, Kim YS, Jeong HJ, Lim BJ.
    Transplant Proc; 2019 Jun 03; 51(5):1488-1490. PubMed ID: 31053345
    [Abstract] [Full Text] [Related]

  • 17. Significance of C4d deposition in antibody-mediated rejection.
    Takeda A, Otsuka Y, Horike K, Inaguma D, Hiramitsu T, Yamamoto T, Nanmoku K, Goto N, Watarai Y, Uchida K, Morozumi K, Kobayashi T.
    Clin Transplant; 2012 Jul 03; 26 Suppl 24():43-8. PubMed ID: 22747475
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection.
    Sis B, Halloran PF.
    Curr Opin Organ Transplant; 2010 Feb 03; 15(1):42-8. PubMed ID: 20009933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.